Through years of developing cultivation facilities, we’re able to apply our expertise across various continents and cultivate in a variety of formats, from highly-automated indoor grows to multi-hectare outdoor farms. Our cultivation operations are fully diversified to serve both regulated medical markets and rapidly evolving consumer markets, and we’re positioned for the long run with a strong focus on cost-competitiveness.
We’ve continued to live up to the MPX reputation for best-in-class cannabis concentrates and extracts. Our proprietary SOPs have been developed to highly sophisticated US standards and are being implemented into our GMP medical production facilities and Swiss extraction laboratory. We utilize high-capacity supercritical C02, as well as ethanol extraction processes, coupled with cutting-edge distillation and formulation equipment.
With over 90 medical SKUs and 60 consumer and wellness SKUs, our diverse portfolio of products caters to a wide range of patients and consumers. We actively formulate using 9 different cannabinoids and take pride in ensuring product quality is consistent from market to market.
Whether as a showcase for our brands or an outlet for 3rd party brands, we aim to set the bar high in new markets. Through education and engaging retail experiences, we are giving consumers a look into the exciting world of new cannabis and cannabinoid innovations.
5255 Yonge Street, Suite 701
+1 (416) 840-3725
Holyworld SA, MPXI Labs SA & CBDetc
52 Route de Divonne